EUCTR2007-003262-17-DE进行中（未招募）不适用
Impact of irbesartan on oxidative stress and C-reactive protein levels in patients with persistent atrial fibrillation - CREATIVE-AF
niversity Hospital Magdeburg0 个研究点目标入组 60 人开始时间: 2008年7月8日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients with persistent/permanent AF (> 2 months)
- •CHADS2 Score > 2
- •Patient informed orally and in writing
- •Written informed consent of the patient
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •§Strong clinical evidence that prevents the temporary pause of therapy with AT II antagonists
- •§Symptomatic bradycardia
- •§Implanted pacemaker or implanted cardioverter/defibrillator with any antitachycardiac algorithm in use
- •§Cardiac surgery or cardiac catheter ablation within the last 3 months
- •§Typical angina pectoris symptoms at rest or during exercise
- •§Known coronary artery disease with indication for intervention
- •§Symptomatic peripheral vascular disease
- •§Left ventricular ejection fraction < 35%
- •§Myocardial infarction within 6 months of screening
- •§Diastolic blood pressure > 110mm Hg at rest
- •§Symptomatic arterial hypotension
- •§Known renal artery stenosis
- •§serum creatinin > 1.8 mval/l
- •§chronic inflammatory disease
- •§acute inflammatory disease (hsCRP > 20mg/L)
- •§Relevant hepatic or pulmonary disorders
- •§Hyperthyreosis manifested clinically and in laboratory
- •§Known drug intolerance for AT II inhibitors
- •§Females who are pregnant or breast feeding
- •§Females of childbearing potential who are not using a scientifically accepted method of contraception
- •§Participation in a clinical trial within the last 30 days
- •§Drug addiction or chronic alcohol abuse
- •§Legal incapacity, or other circumstances which would prevent the patient from understanding the aim, nature or extent of the clinical study, Evidence of an uncooperative attitude
研究者
相似试验
Unknown
4 期
Irbesartan and Adhesion Molecules in AFPersistent Atrial FibrillationNCT00613496University of Magdeburg60
进行中（未招募）
不适用
Olmesartan, Oxidant Stress and in Vivo Re-Endothelialization Capacity of Endothelial Progenitor Cells from Patients with Chronic Kidney Disease (OECD Study) - OECD StudyEUCTR2008-003249-10-DEniversity of the Saarland
招募中
3 期
Effect of Atorvastatin Usage on Patients with Oral squamous cell carcinomaOral squamous cell carcinoma.Malignant neoplasm of mouth, unspecifiedC06.9IRCT20230627058596N1Karaj University of Medical Sciences30
已完成
不适用
The effect of Irbesartan for cardiac function in patients with atrial fibrillatioJPRN-UMIN000004607Kawasaki medical school, Division of cardiology50
已完成
不适用
The effect of valsartan on oxidative stress in type 2 diabetic patients with hypertension: prospective, randomized, open label, active control, multi-center studyDiseases of the circulatory systemKCT0001498Ajou University Hospital70